Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • newbietonextgen
    Member
    • Nov 2010
    • 56

    Calling multiple BAM files for SNPs and vcf

    Hi all,

    I am in the process of calling SNPs using GATK. I do know that the unifiedgenotyper will call from multiple BAM files. The question is about the resulting VCF file.
    1) Does the VCF file separate out the SNps? In other words, will i know which BAM sample file contributed to what SNP in the VCF file? In such as way i could just parse back individual sample SNPs back, if needed.
    2) Also it it better to call SNPs from individual files or pool all the BAM files from the same treatment to get better depth?

    The BAMs have unique Read Groups. Any help will a appreciated.

    Thanks
    Last edited by newbietonextgen; 04-18-2011, 09:51 AM.
  • jstjohn
    Member
    • Jun 2010
    • 35

    #2
    1. I think GATK uses the Read Group tag to partition the data into separate organisms for variant calling. If you want them treated as the same sample then you give them all the same read group tag, while if you want them treated differently then give them different read group tags. I am actually not 100% sure that "read group" is the right tag for this, so someone please correct me if thats not the case.

    There is a program in the Picard package to manipulate the read group along with other tags in bam files.

    2. Read through this page which describes the different suggested protocals in order of how good they are thought to perform vs computational time involved. I think the best (and slowest) option is to pool everything. The page gives a good overview of the suggested set of steps to follow to call variants given different computational commitments:

    Comment

    • newbietonextgen
      Member
      • Nov 2010
      • 56

      #3
      Yes, read groups may help in the calling process but when you look a vcf file, can you actually distinguish which BAM file gave rise to particular SNPs?

      Comment

      • d17
        Member
        • Sep 2008
        • 27

        #4
        Originally posted by newbietonextgen View Post
        can you actually distinguish which BAM file gave rise to particular SNPs?
        If you are doing multi-sample calling with each sample in a separate BAM, it doesn't always make sense to say that one BAM file gave rise to a particular SNP. For example you could have three samples each of which has weak evidence for a particular SNP: not enough to call the SNP if you are analyzing the samples separately but when you pool them together the combined evidence is sufficient to call a SNP.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Working...